This meta-analysis was conducted with the aim to assess the safety and efficacy of
favipiravir in treating patients with coronavirus disease 2019 (COVID-19). It was carried out …

Introduction An outbreak of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
was reported in Wuhan, China in mid-December 2019, and declared a pandemic by the …

The novel coronavirus outbreak began in late December 2019 and rapidly spread
worldwide, critically impacting public health systems. A number of already approved and …

Background This meta-analysis of randomized controlled trials (RCTs) investigated the
clinical efficacy and safety of favipiravir for patients with mild-to-critical COVID-19. Methods …

Objectives This study aimed to evaluate the efficacy and adverse events of favipiravir in
patients with COVID-19. Methods Our protocol was registered on PROSPERO …

Introduction An outbreak of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
was reported in Wuhan, China, in mid-December 2019, and declared a pandemic by the …

Background Favipiravir possesses high utility for treating patients with COVID-19. However,
research examining the efficacy and safety of favipiravir for patients with COVID-19 is …

We performed a systematic review and meta-analysis for the effectiveness of Favipiravir on
the fatality and the requirement of mechanical ventilation for the treatment of moderate to …

Background The role of favipiravir (FVP) as a COVID-19 treatment is recognized but not fully
elucidated. We aimed to evaluate whether FVP has definite clinical efficacy and safety in the …

Purpose Favipiravir has been used in the therapy of COVID-19, including patients with mild
to moderate symptoms in certain countries. The aim of our systematic review and meta …